These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Hepatotoxicity of long-term methotrexate therapy for psoriasis. Tobias H; Auerbach R Arch Intern Med; 1973 Sep; 132(3):391-6. PubMed ID: 4783020 [No Abstract] [Full Text] [Related]
28. Reliability of the Roenigk classification of liver damage after methotrexate treatment for psoriasis: a clinicopathologic study of 160 liver biopsy specimens. Berends MA; van Oijen MG; Snoek J; van de Kerkhof PC; Drenth JP; Han van Krieken J; de Jong EM Arch Dermatol; 2007 Dec; 143(12):1515-9. PubMed ID: 18087000 [TBL] [Abstract][Full Text] [Related]
29. Systemic methotrexate for the treatment of psoriasis. Yélamos O; Puig L Expert Rev Clin Immunol; 2015 May; 11(5):553-63. PubMed ID: 25779551 [TBL] [Abstract][Full Text] [Related]
30. Severe liver damage caused by treatment of psoriasis with methotrexate. Pai SH; Werthamer S; Zak FG N Y State J Med; 1973 Nov; 73(21):2585-7. PubMed ID: 4518596 [No Abstract] [Full Text] [Related]
31. Letter: anti-TNFs and psoriasis--friends or foes? Guerra I; Gisbert JP Aliment Pharmacol Ther; 2012 Sep; 36(5):497; author reply 498. PubMed ID: 22860613 [No Abstract] [Full Text] [Related]
33. Is methotrexate safe in the treatment of psoriatic patients? Al-Waiz MM; Jafar SJ Saudi Med J; 2004 Apr; 25(4):536-7. PubMed ID: 15083237 [No Abstract] [Full Text] [Related]
34. [Damage due to treatment of psoriasis with folic acid antagonists]. Randazzo SD; Chiarenza A; Lazzaro C G Ital Dermatol Minerva Dermatol; 1972 Feb; 47(2):77-81. PubMed ID: 4260377 [No Abstract] [Full Text] [Related]
35. Alcohol interactions with drugs and its effect on the treatment of skin diseases. Zachariae H Clin Dermatol; 1999; 17(4):443-5. PubMed ID: 10497730 [No Abstract] [Full Text] [Related]
36. [Treatment of severe psoriasis with anti-TNF-alpha-antibody and methotrexate]. Dalaker M; Bonesrønning JH Tidsskr Nor Laegeforen; 2003 Apr; 123(8):1070-1. PubMed ID: 12760225 [No Abstract] [Full Text] [Related]
37. A randomized controlled trial of methotrexate and cyclosporine in the treatment of psoriasis. Bigby M Arch Dermatol; 2004 Mar; 140(3):347-8. PubMed ID: 15023778 [No Abstract] [Full Text] [Related]
38. Palmoplantar pustular psoriasis following initiation of a beta-blocker: disease control with low-dose methotrexate. Stanford CW; Kollipara R; Melookaran AM; Hall JC Cutis; 2014 Sep; 94(3):153-5. PubMed ID: 25279477 [TBL] [Abstract][Full Text] [Related]
39. British Association of Dermatologists' guidelines for the safe and effective prescribing of methotrexate for skin disease 2016. Warren RB; Weatherhead SC; Smith CH; Exton LS; Mohd Mustapa MF; Kirby B; Yesudian PD Br J Dermatol; 2016 Jul; 175(1):23-44. PubMed ID: 27484275 [No Abstract] [Full Text] [Related]
40. Methotrexate or fumarates: which is the best oral treatment for psoriasis? Barker JN Br J Dermatol; 2011 Apr; 164(4):695. PubMed ID: 21457199 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]